← All studies
Journal of Clinical Endocrinology & Metabolism 91: 4335–4343 · 2006Symptoms & thresholds

Association of specific symptoms and metabolic risks with serum testosterone in older men

Zitzmann, Faber and Nieschlag at the Institute of Reproductive Medicine in Münster examined how specific symptoms and metabolic risks map onto serum testosterone in ageing men. They widen the threshold further than Scovell: the first symptoms appeared around 15 nmol/L, but the authors note there was no clear-cut boundary — some men experience symptoms earlier than others. Their cluster analysis is the reason low testosterone should not be read as one syndrome: it presents as three largely independent pictures.

Zitzmann M., Faber S., Nieschlag E.Open the publication DOI: 10.1210/jc.2006-0401

Focus

Symptom clusters & metabolic risk

Published finding

Symptom clusters & metabolic risk

Source

10.1210/jc.2006-0401

Record

Ref 10

Structured abstract

Method

Zitzmann, Faber and Nieschlag at the Institute of Reproductive Medicine in Münster examined how specific symptoms and metabolic risks map onto serum testosterone in ageing men. They widen the threshold further than Scovell: the first symptoms appeared around 15 nmol/L, but the authors note there was no clear-cut boundary — some men experience symptoms earlier than others. Their cluster analysis is the reason low testosterone should not be read as one syndrome: it presents as three largely independent pictures.

Result

Psychosomatic symptoms and metabolic risk factors accumulated progressively as testosterone fell. Loss of libido or vigour increased significantly below 15 nmol/L (P < 0.001). Depression and type 2 diabetes — also in non-obese men — were significantly more present below 10 nmol/L. Cluster analysis revealed three independent groups: psychosomatic complaints, metabolic disorders, and sexual health problems.

What to take with you

Libido and vigour rose below 15 nmol/L. Depression and type 2 diabetes were clearly more common below 10 nmol/L. The thresholds describe where symptoms gathered.

Why it matters

Libido and vigour rose below 15 nmol/L; depression and type 2 diabetes were clearly more common below 10 nmol/L — a map of where symptoms gather.

Study frame

Symptom clusters & metabolic risk

Zitzmann, Faber and Nieschlag at the Institute of Reproductive Medicine in Münster examined how specific symptoms and metabolic risks map onto serum testosterone in ageing men. They widen the threshold further than Scovell: the first symptoms appeared around 15 nmol/L, but the authors note there was no clear-cut boundary — some men experience symptoms earlier than others. Their cluster analysis is the reason low testosterone should not be read as one syndrome: it presents as three largely independent pictures.

Finding

Psychosomatic symptoms and metabolic risk factors accumulated progressively as testosterone fell.

Contrast

Loss of libido or vigour increased significantly below 15 nmol/L (P < 0.001).

Context

Depression and type 2 diabetes — also in non-obese men — were significantly more present below 10 nmol/L.

DOI

10.1210/jc.2006-0401

Category

Symptom clusters & metabolic risk

Findings listed

4

Type

As published

What to take from the numbers

Boxes below use only wording already in the published summary for this study.

Reported finding

1

Psychosomatic symptoms and metabolic risk factors accumulated progressively as testosterone fell.

Reported finding

15 nmol/L

Loss of libido or vigour increased significantly below 15 nmol/L (P < 0.001).

Reported finding

2

Depression and type 2 diabetes — also in non-obese men — were significantly more present below 10 nmol/L.

Cross-sectional associations describe how prevalence changes with level; they do not by themselves prove that raising the level removes the symptom.

Why it matters when reading your own result

Pulled from the study's own findings.

Psychosomatic symptoms and metabolic risk factors accumulated progressively as testosterone fell.

Symptom clusters & metabolic risk

Loss of libido or vigour increased significantly below 15 nmol/L (P < 0.001).

Symptom clusters & metabolic risk

Depression and type 2 diabetes — also in non-obese men — were significantly more present below 10 nmol/L.

Symptom clusters & metabolic risk

Clinical reading

How to use this page

Zitzmann, Faber and Nieschlag at the Institute of Reproductive Medicine in Münster examined how specific symptoms and metabolic risks map onto serum testosterone in ageing men. They widen the threshold further than Scovell: the first symptoms appeared around 15 nmol/L, but the authors note there was no clear-cut boundary — some men experience symptoms earlier than others. Their cluster analysis is the reason low testosterone should not be read as one syndrome: it presents as three largely independent pictures.

Your own numbers

Measure before you decide what this page means for you.

The figures here describe men who were actually measured.

  • Total testosterone and SHBG
  • Symptoms written down
  • Haematocrit as a safety baseline
  • Repeat labs before any protocol change